Here's how much BCCI is offering for Tully's info from

New Post Public Reply Private Reply Replies (0) Message Board
bcci

Here's how much BCCI is offering for Tully's info from Court papers

Looks good, on paper BCCI is offering $5.8 million more than only other bidder. They could win this one and end up owning Tullys.

But in court papers filed last week, Baristas sketched out a proposal to pay about $1.5 million in cash, take on about $2.8 million in existing liabilities, and issue $6 million in unspecified “negotiable securities” to unsecured creditors and shareholders of Tully’s.

Its offer must compete with the only confirmed bidder, a Colorado private equity firm that offered to pay $1.5 million in cash and assume about $3 million in existing liabilities.

Baristas said Tuesday it will bid through a new entity, Baristas Acquisition Partners, that includes several current Tully’s shareholders and other investors.

Baristas Offers to Acquire "Tully's"

http://baristastv.com/press

Today : Wednesday 12 December 2012

SEATTLE, Dec. 11, 2012 /PRNewswire/ -- Baristas Coffee Company, Inc. (OTCPK: BCCI) announced that it has filed an offer to purchase all of the assets of TC Global, Inc. DBA Tully's.   A new company "Baristas Acquisition Partners, Inc." has been formed to complete an offer which, if accepted by the Court, will become a wholly owned subsidiary of BCCI and is backed by current Tully's shareholders and other investors. The Bankruptcy Court has set Jan. 11, 2013 as the hearing date for approval of the sale of Tully's assets.  The BAPI proposal would continue to maintain and operate the Tully's locations with the existing employees under the Tully Coffee brand.

On October 10th, 2012 TC Global, Inc., "Tully's", filed for protection under Chapter 11 of the federal Bankruptcy Code in order to address issues that were preventing it from being profitable. Since filing they have closed unprofitable locations, reduced overhead, secured additional working capital, and through the bankruptcy they will be able to eliminate debt, certain liabilities and unprofitable legacy leases.

Barry Henthorn , CEO of Baristas, stated, "We are overwhelmed with the support we have received both emotionally and financially from existing shareholders of Tully's and many other members of the community. Our offer is the only one that allows any ongoing benefit to the approximately 6000 shareholders and does so while maximizing the returns to the other creditors.  By combining management and supply chain resources it is expected that the combined entities of Baristas and Tully's will be profitable and that operations from just current locations alone will generate in excess of $25 million in revenue and approximately $2 million in profits during 2013.  This acquisition will also allow further distribution of other Baristas products, such as our new Ice Cream line and other products under development."

About Tully's: Tully's was founded in 1992 and currently operates 47 company-owned stores in Washington and California as well as 5 franchised locations and 58 licensed locations throughout the Western US.  Tully's also has 9 franchised locations in Asia; 4 stores in Singapore, 3 locations in South Korea and 2 in the Philippines, with the ability to franchise and/or license additional locations throughout Asia, Europe, the Middle East and other regions around the world.  There are also in excess of 400 locations in Japan that Tully's sold the rights to and no longer receives any economic benefit.  Tully's also operates or franchises smaller footprint stores in special venues such as on the premises of manufacturing facilities (Boeing), as well as, kiosks and cafes located in grocery stores, hotels, hospitals, airports, and on university campuses. Tullys has approximately 6000 shareholders.

About BAPI:  Baristas Acquisition Partners, Inc.  (BAPI)  was formed specifically to complete the acquisition of "Tully's" TC Global via a 363 transaction in the US Bankruptcy court. BAPI consists of several current Tully's shareholders, top Financial Analyst, executives from the coffee industry, Baristas (BCCI) shareholders, investment bankers, lawyers, professional athletes, and general investors who have combined their resources in order to complete this acquisition. BAPI will continue to consider additional participants up until the time of the sale.

About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found in six greater Seattle area locations as well as in Arizona, Texas, Florida, and Montana. Your state, Coming Soon!

For more information on this fascinating concept please visit us at www.baristas.tv

For Investor Relations Contact:

Barry Henthorn

http://baristastv.com/press

(206)579-0222

For Press Inquiries Contact:

Richard Lewis

rlewis@richardlewispr.com

818-907-6417

SOURCE Baristas Coffee Company, Inc.

Copyright 2012 PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 938

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 289

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 309

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 261

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sonic Partners with Obsessed Garage for Home Garage Solutions

Updated Category News Views 147

Sonic Teams Up with Obsessed Garage to Transform Home Garages Sonic, a front-runner in delivering high-quality tool solutions and equipment, has recently announced an exciting partnership with Obsessed Garage. This collaboration aims to cater to home garage enthusiasts who demand tools and storage solutions that match the quality standards utilized by professionals in the...

Continue Reading
Investors of Sun Communities, Inc. Urged to Act Before Deadline

Updated Category News Views 167

Important Update for Sun Communities, Inc. Investors There is a significant call to action for investors of Sun Communities, Inc. as a class action lawsuit has been filed against the company, urging those affected to act promptly. This is a crucial moment for investors who purchased securities from the company during a specific period. Legal representation is being...

Continue Reading
XOMA Stock Reaches New Heights: Key Developments and Insights

Updated Category News Views 67

XOMA Stock Performance Overview XOMA Ltd's stock has recently made headlines by reaching a remarkable 52-week high, with shares trading at an impressive $30.49. This achievement not only signifies a significant milestone for the company but also highlights a robust year-over-year growth that can't be overlooked. Investors have observed a substantial increase of 73.82% in...

Continue Reading
Evolv Technologies Faces Turmoil with Executive Departures

Updated Category News Views 230

Evolv Technologies Faces Turmoil with Executive Departures Evolv Technologies Holdings (NASDAQ: EVLV) is navigating turbulent times following the resignation of its Chief Financial Officer, Mark Donohue. His departure comes amid serious allegations of improper revenue recognition practices that have raised questions about the company's integrity and financial health....

Continue Reading
Editas Medicine: Financial Insights and Market Strategies Revealed

Updated Category News Views 56

Editas Medicine Maintains Price Target Amidst Financial Developments Recently, Leerink Partners reaffirmed a Market Perform rating for Editas Medicine (NASDAQ: EDIT), keeping a price target steady at $8.00. This decision comes closely after the company announced a substantial financing agreement with DRI Healthcare Trust. Under this agreement, Editas is set to receive an...

Continue Reading